Bacillus amyloliquefaciens
Bacillus amyloliquefaciens is a spore-forming soil bacterium known primarily for its enzyme-producing capabilities and agricultural biocontrol applications — including suppression of plant pathogens and promotion of plant growth. The available research for this organism in this index is almost entirely environmental or agricultural in nature, with no human clinical trial evidence and only limited characterization as a potential feed additive for livestock. It is not a recognized human probiotic strain in the conventional sense; its research context is overwhelmingly agro-industrial. Human health applications for this organism are not supported by the available strain-specific evidence.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 697 body-system-tagged papers that concern each system. Research coverage, not measured effect.
Symptoms in the research A tag means the paper's text names the symptom or condition — research coverage, not evidence of benefit. How we classify this →
Share of this strain's 115 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
3737 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.
Citations
Selected papers that name this strain.
-
[1]
PMID 41897699 →Detoxification of Ochratoxin A by Bacillus amyloliquefaciens MM28: Whole-Genome Sequencing and Safety Evaluation of a Novel Probiotic Strain· Foods · 2026
-
[2]
PMID 41818344 →Polystyrene-degrading bacteria modulate host stress and toxicity responses to microplastic exposure in Caenorhabditis elegans· The ISME Journal · 2026
-
[3]
Source →Therapeutic Potential of Bacillus amyloliquefaciens NPKE6 Fermented Metabolites with Superoxide Dismutase (SOD)-Mediated Antioxidant and Anti-Inflammatory Effects in Liver Injury and Colitis Animal Models· Fermentation · 2026
-
[4]
Source →Enhancing the Biocontrol Potential of Bacillus amyloliquefaciens by Hydrogel Encapsulation for Combating Intestinal Pathogens· · 2026
-
[5]
PMID 40892163 →Genomic and Phenotypic Evaluation of the Gliadin-Degrading Probiotic Bacillus amyloliquefaciens EG025 from Cheonggukjang for Celiac Disease Treatment· Probiotics and Antimicrobial Proteins · 2025
-
[6]
PMID 40391335 →Safety evaluation of the food enzyme 4‐α‐glucanotransferase from the genetically modified Bacillus amyloliquefaciens strain MAS· EFSA Journal · 2025
-
[7]
Source →Targeted detection of microbes in synbiotic medical foods SBD111 and SBD121 to evaluate gut persistence: a randomised, open label trial· medRxiv · 2025
-
[8]
Source →The effect of bacillus amyloliquefaciens on the body of goats· Bulletin Samara State Agricultural Academy · 2024
-
[9]
PMID 37388456 →Feeding Bacillus-based probiotics to gestating and lactating sows is an efficient method for improving immunity, gut functional status and biofilm formation by probiotic bacteria in piglets at weaning· Animal nutrition · 2023
-
[10]
Source →Bacillus amyloliquefaciens exopolysaccharides promote the defensive and protective functions of intestinal epithelial cells· · 2023